Macomics is a spinout from the University of Edinburgh and is backed by a supportive and experienced investor syndicate

Epidarex Capital is a transatlantic venture firm that invests in early stage, high-growth life science companies in under-ventured markets. Epidarex focuses on providing risk capital and expertise to create, support, and build young companies, including spinouts, from leading research institutions in both established and emerging life science hubs.

LifeLink Ventures are an investment fund closing the gap between private capital and exciting new investment opportunities that tackle global health challenges. The LifeLink Ventures team is based in Barcelona, Spain, and they search for companies and work with investors across Europe and beyond. LifeLink Ventures deploy capital in alignment with a powerful cause – improvement in global health.

Scottish Enterprise is Scotland’s national economic development agency and a non-departmental public body of the Scottish Government. To deliver a significant, lasting effect on the Scottish economy, we work with partners in the public and private sectors to find and exploit the best opportunities.

The University of Edinburgh is one of the world’s top universities. Our partnership with the University of Edinburgh has allowed access to intellectual property that has enabled the development and progression of our portfolio.